Evidence map›Paper›PMID 22025623›Full record

ArticleJournal of the National Cancer Institute2011

pIgR: frenemy of inflammation, EMT, and HCC progression.

Nathalie Sphyris, Sendurai A Mani

Abstract readEditorialComment
In one paragraph

Article in Journal of the National Cancer Institute, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. EMT and Inflammation: Crossroads in HCC.Journal of gastrointestinal cancer · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Nathalie Sphyris
Sendurai A Mani

Funding

Pleiotropic functions of FOXC2 in EMT, stem cells and breast cancer progressionR01CA155243 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MANI, SENDURAI AYYAVOO · 2011 to 2022
$3.2M
NCI NIH HHS R01 CA155243
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell Transformation, NeoplasticEpithelial CellsMesenchymal Stem CellsAnimalsBiomarkers, TumorCarcinoma, HepatocellularFemaleHepatitis B, ChronicHumansLiver NeoplasmsLung NeoplasmsMaleReceptors, Polymeric ImmunoglobulinBiomarkers, TumorReceptors, Polymeric Immunoglobulin

Identifiers

PMID22025623
PMCPMC3216969

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.